BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38057257)

  • 1. Cancer-related arterial thromboembolic events.
    Pernod G; Cohen A; Mismetti P; Sanchez O; Mahé I;
    Arch Cardiovasc Dis; 2024 Jan; 117(1):101-113. PubMed ID: 38057257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migraine and risk of cardiovascular diseases: Danish population based matched cohort study.
    Adelborg K; Szépligeti SK; Holland-Bill L; Ehrenstein V; Horváth-Puhó E; Henderson VW; Sørensen HT
    BMJ; 2018 Jan; 360():k96. PubMed ID: 29386181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial Ischemic Events Are a Major Complication in Cancer Patients with Venous Thromboembolism.
    Brenner B; Bikdeli B; Tzoran I; Madridano O; López-Reyes R; Suriñach JM; Blanco-Molina Á; Tufano A; Núñez JJL; Trujillo-Santos J; Monreal M;
    Am J Med; 2018 Sep; 131(9):1095-1103. PubMed ID: 29807000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
    Friberg L; Rosenqvist M; Lip GY
    Eur Heart J; 2012 Jun; 33(12):1500-10. PubMed ID: 22246443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of arterial and venous thromboembolism in patients with atrial fibrillation or flutter: A nationwide population-based cohort study.
    Sundbøll J; Hováth-Puhó E; Adelborg K; Ording A; Schmidt M; Bøtker HE; Sørensen HT
    Int J Cardiol; 2017 Aug; 241():182-187. PubMed ID: 28473169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting outcomes in patients with cancer and atrial fibrillation.
    Gutierrez A; Patell R; Rybicki L; Khorana AA
    Ther Adv Cardiovasc Dis; 2019; 13():1753944719860676. PubMed ID: 31319783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society.
    Gorog DA; Gue YX; Chao TF; Fauchier L; Ferreiro JL; Huber K; Konstantinidis SV; Lane DA; Marin F; Oldgren J; Potpara T; Roldan V; Rubboli A; Sibbing D; Tse HF; Vilahur G; Lip GYH
    Europace; 2022 Nov; 24(11):1844-1871. PubMed ID: 35323922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Traumatic Subdural Hemorrhage and Risk of Arterial Ischemic Events.
    Murthy SB; Wu X; Diaz I; Parasram M; Parikh NS; Iadecola C; Merkler AE; Falcone GJ; Brown S; Biffi A; Ch'ang J; Knopman J; Stieg PE; Navi BB; Sheth KN; Kamel H
    Stroke; 2020 May; 51(5):1464-1469. PubMed ID: 32178587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should We Reintroduce Previous Venous Thromboembolism Into Decision-Making for Anticoagulation in Atrial Fibrillation?
    Overvad TF; Skjøth F; Albertsen IE; Larsen TB; Søgaard M; Lip GYH
    Am J Med; 2021 Jan; 134(1):67-75.e5. PubMed ID: 32634387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous Thromboembolism and Atherosclerotic Events in Patients With Non-Valvular Atrial Fibrillation.
    Thomopoulos C
    Angiology; 2022 May; 73(5):393-394. PubMed ID: 34989250
    [No Abstract]   [Full Text] [Related]  

  • 11. New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders.
    Dahl OE
    Vasc Health Risk Manag; 2012; 8():45-57. PubMed ID: 22323896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and Risk of Various Types of Arterial Thromboembolism in Patients With Cancer.
    Wang J; Kim YD; Kim CH
    Mayo Clin Proc; 2021 Mar; 96(3):592-600. PubMed ID: 33673912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study.
    Sørensen HT; Horvath-Puho E; Søgaard KK; Christensen S; Johnsen SP; Thomsen RW; Prandoni P; Baron JA
    J Thromb Haemost; 2009 Apr; 7(4):521-8. PubMed ID: 19192118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
    BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
    Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
    JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anticoagulation in atrial fibrillation. Strategies in special situations].
    Volkmann H; Walter M; Walter C; Vetter S
    Clin Res Cardiol Suppl; 2011 May; 6():58-65. PubMed ID: 22528179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical manifestations and thrombotic risk factors in primary antiphospholipid syndrome].
    Zhao JL; Sun YD; Zhang Y; Xu D; Wang Q; Li MT; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2016 May; 55(5):386-91. PubMed ID: 27143190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult height and risk of ischemic heart disease, atrial fibrillation, stroke, venous thromboembolism, and premature death: a population based 36-year follow-up study.
    Schmidt M; Bøtker HE; Pedersen L; Sørensen HT
    Eur J Epidemiol; 2014 Feb; 29(2):111-8. PubMed ID: 24337942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation risk assessment for patients with non-valvular atrial fibrillation and venous thromboembolism: A clinical review.
    Pallazola VA; Kapoor RK; Kapoor K; McEvoy JW; Blumenthal RS; Gluckman TJ
    Vasc Med; 2019 Apr; 24(2):141-152. PubMed ID: 30755150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of atherosclerotic vascular disease in predicting a stroke, thromboembolism and mortality in atrial fibrillation patients: a systematic review.
    Anandasundaram B; Lane DA; Apostolakis S; Lip GY
    J Thromb Haemost; 2013 May; 11(5):975-87. PubMed ID: 23441593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.